Natixis Advisors LLC Grows Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Natixis Advisors LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 10.1% during the 4th quarter, HoldingsChannel reports. The fund owned 116,809 shares of the medical device company’s stock after buying an additional 10,706 shares during the period. Natixis Advisors LLC’s holdings in Cooper Companies were worth $10,738,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Fulton Bank N.A. boosted its stake in Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after purchasing an additional 109 shares in the last quarter. Torray Investment Partners LLC lifted its stake in shares of Cooper Companies by 0.8% in the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after buying an additional 132 shares in the last quarter. Mather Group LLC. grew its holdings in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after buying an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares in the last quarter. Finally, Greenleaf Trust increased its position in shares of Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after acquiring an additional 139 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.1 %

Shares of Cooper Companies stock opened at $80.12 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock has a market capitalization of $16.02 billion, a PE ratio of 41.09, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 1-year low of $77.05 and a 1-year high of $112.38. The company’s fifty day simple moving average is $90.45 and its 200-day simple moving average is $98.44.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird reduced their price objective on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday, March 7th. Citigroup decreased their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.